Interesting facts
Interesting Facts about (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
This compound, with its complex structure, represents a fascinating area of inquiry in organic chemistry. Here are some captivating aspects to consider:
- Complex Architecture: The intricate arrangement of rings and functional groups showcased in this molecule is a hallmark of advanced organic compounds. Its pentacyclic structure is a fine example of molecular diversity and can be explored for its intriguing stereochemical properties.
- Potential Biological Activity: Owing to its diverse functional groups, this compound is a candidate for pharmaceutical research. Similar compounds play a role in drug development, particularly in targeting specific biological pathways.
- Natural Product Inspiration: Many complex organic compounds are derived from natural products. This compound's structure reflects the natural diversity observed in various biological systems and can inspire synthetic approaches to mimic or enhance natural functions.
- Applications in Material Science: The unique structural features of this compound could translate into novel materials with specific optical or electronic properties, contributing significantly to the field of nanotechnology.
- Namesake Chemistry: The nomenclature of this compound reveals its rich history—each part of the name highlights specific aspects such as its stereochemistry, functional groups, and core structure, reflecting the depth of organic chemistry's systematic naming conventions.
In conclusion, the study of this compound not only enhances our understanding of complex molecular structures but also opens doors to potential applications in various scientific fields, from medicinal chemistry to materials science. The journey of exploring such compounds is as complex and rewarding as the structures themselves!
Synonyms
camptothecin
Camptothecine
7689-03-4
(S)-(+)-Camptothecin
(+)-Camptothecin
d-Camptothecin
(+)-Camptothecine
20(S)-Camptothecine
21,22-Secocamptothecin-21-oic acid lactone
NSC94600
d-camptothecine
(s)-camptothecine
NSC-94600
XT3Z54Z28A
Camptothecine (8CI)
CHEBI:27656
(4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
CAMPTOTHECIN [MI]
(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
CAMPTOTHECIN [WHO-DD]
CCRIS 8162
DTXSID0030956
NSC 94600
BRN 0631069
AI3-62475
1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (4S)-
1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (4S)-
(4S)-4-ETHYL-4-HYDROXY-1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H,12H)-DIONE
(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo(11.8.0.02,11.04,9.015,20)henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
(S)-4-ethyl-4-hydroxy-1H-pyrano-(3',4':6,7)indolozino(1,2-b)quinoline-3,14(4H,12H)-dione
(S)-4-ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolozino[1,2-b]quinoline-3,14(4H,12H)-dione
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-
20-(S)-camptothecine
DTXCID8010956
21, 22-Secocamptothecin-21-oic acid lactone
1H-Pyrano(3',3'.6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4hydroxy-(S)-
1H-Pyrano[3',3'.6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4hydroxy-(S)-(9CI)
vsjkwcgypahwds-fqevstjzsa-n
Campathecin
(S)-4-ethyl-4-hydroxy-1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
Camptothecine (S,+)
CHEMBL65
MFCD00081076
MLS000766223
NSC 100880
(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
(S)-Camptothecin
20(S)-Camptothecin
4-ETHYL-4-HYDROXY-1,12-DIHYDRO-4H-2-OXA-6,12A-DIAZA-DIBENZO[B,H]FLUORENE-3,13-DIONE
SR-01000075798
SR-01000597379
(S)-4-ethyl-4-hydroxy-1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione
Prestwick_102
Spectrum_000299
Tocris-1100
SpecPlus_000712
Prestwick0_000200
Prestwick1_000200
Prestwick2_000200
Prestwick3_000200
Spectrum2_000903
Spectrum3_001203
Spectrum4_000738
Spectrum5_001126
Lopac-C-9911
SCHEMBL6038
UNII-XT3Z54Z28A
Lopac0_000341
BSPBio_000159
BSPBio_002586
KBioGR_001036
KBioSS_000779
KBioSS_002283
cid_24360
DivK1c_000826
DivK1c_006808
SPECTRUM1502232
SPBio_000746
SPBio_002080
BPBio1_000175
HMS502J08
KBio1_000826
KBio1_001752
KBio2_000779
KBio2_003347
KBio2_005915
KBio3_002086
4-Ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
NINDS_000826
Bio1_000400
Bio1_000889
Bio1_001378
GLXC-10346
HMS1568H21
HMS1921N08
HMS2089F08
HMS2095H21
HMS3261E03
HMS3414J17
HMS3654D13
HMS3678J15
HMS3712H21
BCP02857
MSK40312
Tox21_500341
AC-202
BBL033963
BDBM50008923
CCG-40255
GR-301
s1288
STK801886
AKOS004119861
CS-1049
DB04690
FC15450
KS-5235
LP00341
SDCCGMLS-0066688.P001
SDCCGSBI-0050329.P003
CAS-2114454
IDI1_000826
NCGC00015290-01
NCGC00016994-01
NCGC00016994-02
NCGC00016994-03
NCGC00016994-04
NCGC00016994-05
NCGC00016994-06
NCGC00016994-07
NCGC00016994-08
NCGC00016994-09
NCGC00016994-10
NCGC00016994-11
NCGC00016994-12
NCGC00016994-16
NCGC00016994-19
NCGC00016994-23
NCGC00016994-29
NCGC00024997-01
NCGC00024997-02
NCGC00024997-03
NCGC00024997-04
NCGC00024997-05
NCGC00024997-06
NCGC00178592-01
NCGC00178592-02
NCGC00261026-01
1ST40312
HY-16560
NCI60_042105
SMR000445686
SY010324
EU-0100341
NS00011856
SW196414-3
C 9911
C01897
M01564
AB00052452-08
AB00052452-09
AB00052452_10
EN300-1725804
(S)-(+)-Camptothecin, >=90% (HPLC), powder
Q419964
SR-01000075798-1
SR-01000075798-4
SR-01000597379-1
SR-01000597379-3
BRD-K37890730-001-09-4
BRD-K37890730-001-10-2
BRD-K37890730-001-15-1
BRD-K37890730-001-16-9
BRD-K37890730-001-17-7
Z1741982070
(S)-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]florene-3,13-dione
(S)-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
4-Ethyl-4-hydroxy-1H-pyrano-[3,4:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
4-Ethyl-4-hydroxy-1H-pyrano-[3[,4[:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
(S)-4-Ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione;Camptothecine
(S)-4-Ethyl-4-hydroxy-1H-pyrano[3 inverted exclamation mark ,4 inverted exclamation mark :6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione
1H-Pyrano[3',7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-
4(S)-Ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolizino[1,2-b]quinoline-3,14 (4H,12H)-dione
4-ethyl-4-hydroxy-(4S)-3,4,12,14-tetrahydro-1H-pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-3,14-dione
4-Ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (camptothecin or CPT)
4-Ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (Camptothecin)
4-Ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (CPT, Camptothecin)
Solubility of (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
The solubility of complex organic compounds like (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione can be quite intricate. Here are some considerations regarding its solubility:
In conclusion, while the general trends of solubility can be anticipated based on structural features, empirical testing is essential to accurately determine the solubility of such a complex compound. As the saying goes, "The proof of the pudding is in the eating." Thus, practical experiments will shed light on its true solubility behavior.